Webinars & e-learning courses Advanced All webinars

Hemangiosarcoma – Beyond Surgery

Hemangiosarcoma – Beyond Surgery
Hemangiosarcoma – Beyond Surgery

Hemangiosarcoma is a common canine cancer that can affect any tissue in the body. Some sites and subtypes of hemangiosarcoma are better than others. Whilst surgery is commonly the first treatment option for hemangiosarcoma, there are a few other treatments that can be helpful for patients with this diagnosis. 

Recording from 14 January 2025

Speaker:

Penny.jpg

Penny Thomas

BVSc Hons1, MANZCVS, FANZCVS

Dr Penny Thomas graduated from the University of Sydney in 2011 and initially spent time in mixed practice in the NSW Hunter Valley. She went on to undergo her internship and residency training at the Small Animal Specialist Hospital in Sydney. During the course of her training she spent time at Colorado State University, The Animal Health Trust in the UK, University of Madison Wisconsin and time in the Chris O’Brien Lifehouse in Sydney. She obtained her memberships in Small Animal Medicine from the Australian and New Zealand College of Veterinary Scientists in 2015.

She became a Fellow of the college in 2019 and is a Registered Specialist in Veterinary Oncology. She has recently undergone postgraduate study in Psychology and has helped mentor many recent graduate veterinarians. Penny has a passion for providing educational materials and mentorship to her fellow veterinarians, and veterinary nurses and believes that the patients quality of life is by far the most important part of cancer treatment.

Booking information

Duration: 0:48 h
Speaker: Penny Thomas
from 1
54.90 US$
(inkl. tax)

You might also be interested in

300x200.jpg
Momoko Ito
0:53 h

Nursing the end-stage cancer patient 

As veterinary patients age, they are more susceptible to diseases and cancer. This webinar will cover the basic cancer biology, treatment options and palliative care... 
staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient

Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.
canine-mast-cell-tumors-1.jpeg
Evi Pecceu
0:43 h

Canine Mast Cell Tumours

Canine mast cell tumours are common in general practice. The diagnosis is usually straightforward by means of fine needle aspiration; however, management can be challenging due to the variable behaviour ranging from locally infiltrating lesions to aggressive mast cell tumours metastasising to the liver and spleen. As a consequence, outcomes range from weeks to years. The aim of the webinar is to focus on the use of prognostic factors to predict the behaviour of mast cell tumours and to guide management of each individual case. Once the extent of disease and likely prognosis has been established, a plethora of treatment options need to be considered including surgery, radiation therapy, chemotherapy, targeted therapy, palliative supportive care as sole or multi-modal therapy. Dogs with a good prognosis should be offered treatment options aimed at long term control, whereas the focus for dogs with a poor prognosis might need to be palliative. The second part of the webinar is focused on highlighting when to consider which treatment options.